194 related articles for article (PubMed ID: 21045156)
21. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
22. WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.
Chen Y; Mu X; Wang S; Zhao L; Wu Y; Li J; Li M
Oncol Rep; 2013 Jan; 29(1):288-96. PubMed ID: 23129262
[TBL] [Abstract][Full Text] [Related]
23. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
24. Molecular regulation of ovarian cancer cell invasion.
Sun N; Zhang Q; Xu C; Zhao Q; Ma Y; Lu X; Wang L; Li W
Tumour Biol; 2014 Nov; 35(11):11359-66. PubMed ID: 25119590
[TBL] [Abstract][Full Text] [Related]
25. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
26. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
28. VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation.
Shathasivam P; Kollara A; Spybey T; Park S; Clarke B; Ringuette MJ; Brown TJ
Br J Cancer; 2017 Apr; 116(8):1065-1076. PubMed ID: 28301874
[TBL] [Abstract][Full Text] [Related]
29. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
30. A mechanistic study on the anti-cancer activity of ethyl caffeate in human ovarian cancer SKOV-3 cells.
Lee HN; Kim JK; Kim JH; Lee SJ; Ahn EK; Oh JS; Seo DW
Chem Biol Interact; 2014 Aug; 219():151-8. PubMed ID: 24892518
[TBL] [Abstract][Full Text] [Related]
31. Distal-less homeobox 5 promotes the osteo-/dentinogenic differentiation potential of stem cells from apical papilla by activating histone demethylase KDM4B through a positive feedback mechanism.
Yang H; Fan J; Cao Y; Gao R; Fan Z
Exp Cell Res; 2019 Jan; 374(1):221-230. PubMed ID: 30503866
[TBL] [Abstract][Full Text] [Related]
32. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
[TBL] [Abstract][Full Text] [Related]
33. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
34. Upregulated osterix expression elicited by Runx2 and Dlx5 is required for the accelerated osteoblast differentiation in PP2A Cα-knockdown cells.
Yang D; Okamura H; Qiu L
Cell Biol Int; 2018 Apr; 42(4):403-410. PubMed ID: 29068100
[TBL] [Abstract][Full Text] [Related]
35. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins.
Kuwajima T; Nishimura I; Yoshikawa K
J Neurosci; 2006 May; 26(20):5383-92. PubMed ID: 16707790
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
[TBL] [Abstract][Full Text] [Related]
37. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.
Lee MH; Kim YJ; Yoon WJ; Kim JI; Kim BG; Hwang YS; Wozney JM; Chi XZ; Bae SC; Choi KY; Cho JY; Choi JY; Ryoo HM
J Biol Chem; 2005 Oct; 280(42):35579-87. PubMed ID: 16115867
[TBL] [Abstract][Full Text] [Related]
38. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
[No Abstract] [Full Text] [Related]
40. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Li N; Gou JH; Xiong J; You JJ; Li ZY
BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
